Compounds > omega-n-methylarginine
Page last updated: 2024-09-03

omega-n-methylarginine and Critical Illness

omega-n-methylarginine has been researched along with Critical Illness in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parrillo, JE; Phillip Dellinger, R1
Banks, SM; Danner, RL; Freeman, BD; Natanson, C1

Other Studies

2 other study(ies) available for omega-n-methylarginine and Critical Illness

ArticleYear
Mediator modulation therapy of severe sepsis and septic shock: does it work?
    Critical care medicine, 2004, Volume: 32, Issue:1

    Topics: Bacteremia; Critical Care; Critical Illness; Female; Follow-Up Studies; Humans; Male; omega-N-Methylarginine; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Shock, Septic; Survival Analysis; Systemic Inflammatory Response Syndrome; Treatment Outcome

2004
Safeguarding patients in clinical trials with high mortality rates.
    American journal of respiratory and critical care medicine, 2001, Jul-15, Volume: 164, Issue:2

    Topics: Aspirin; Blood Substitutes; Clinical Trials as Topic; Critical Illness; Hemoglobins; Human Growth Hormone; Humans; omega-N-Methylarginine; Shock, Hemorrhagic; Shock, Septic

2001